Biomarkers can help predict prostate cancer progression, say Johns Hopkins scientists
A blood test for certain forms of prostate specific antigen and measurement of DNA content in biopsy tissue accurately predict which men with potentially non-lethal prostate cancers may eventually need treatment, say Johns Hopkins scientists.

Read more on News-Medical-Net